00

Shandong Shanda Wit Science and Technology Co Ltd

000915 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

19.18CNY-0.43 (-2.19%)

Price History

Full chart

Market Stats

Previous Close19.61
Open19.55
Day Range19.14 – 19.60
52-Week Range23.00 – 33.61
Volume2.46M
Market Cap5.58B
P/E (TTM)13.31
Forward P/E24.81
EPS1.79
Dividend Yield10.60%
Beta0.06
50-Day Avg25.12
200-Day Avg28.94

About

Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, glycyrrhizin zinc granules, compound calcium carbonate, vitamin AD drops, iprastat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration salts, montmorillonite powder, azithromycin granules, rifaximin dry suspension, and dimercaptosuccinic acid capsules. In addition, it offers information products, such as DLP splicing display units, LCD splicing display units, image stitching processors, communication products, and industrial automation control products; and crystal products. The company is also involved in research, development, production, and sales of children's medicines and health products, as well as leasing and property management services. Shandong Wit Dyne Health Co.,Ltd. was founded in 1993 and is based in Jinan, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMs. Jie Yang
  • Employees1.72K
  • HeadquartersHuatai Plaza, No. 17703, Jinan, China, 250061, China
  • Websitehttps://www.sd-wit.com

Leadership

  • Ms. Jie YangMD & Director · b. 1962
  • Mr. Li Fu TanFinancial Director · b. 1978
  • Mr. Shuwang HeDeputy General Manager & Director · b. 1972
  • Mr. Liming FanSecretary of the Board · b. 1986
  • Mr. Long Jiang WangDeputy General Manager · b. 1969

Financials

Income Statement

Currency: CNY1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue141.43M146.40M137.85M102.13M40.03M42.03M99.74M171.68M237.41M336.13M527.43M495.67M538.35M499.40M560.28M716.99M830.25M1.10B1.37B1.23B1.54B1.77B1.53B1.80B1.82B2.03B2.34B2.48B2.13B2.23B
Growth (%)-+3.52%-5.84%-25.91%-60.80%+4.98%+137.32%+72.13%+38.29%+41.58%+56.92%-6.02%+8.61%-7.24%+12.19%+27.97%+15.80%+31.93%+25.44%-10.26%+25.29%+14.40%-13.64%+17.93%+1.17%+11.32%+15.49%+6.11%-14.08%+4.40%
Cost of Revenue105.21M111.81M96.79M59.78M36.29M29.40M64.42M59.06M80.83M124.71M289.48M240.72M266.30M169.36M178.67M253.02M255.07M361.66M521.22M465.07M613.42M572.31M605.23M735.86M716.34M630.37M502.67M339.11M389.59M331.79M
Gross Profit36.22M34.59M41.06M42.34M3.74M12.63M35.32M112.62M156.58M211.42M237.95M254.95M272.05M330.03M381.61M463.96M575.18M733.68M852.74M767.90M931.31M1.19B921.00M1.06B1.10B1.40B1.84B2.15B1.74B1.90B
Gross Margin25.61%23.62%29.79%41.46%9.35%30.05%35.41%65.60%65.95%62.90%45.12%51.44%50.53%66.09%68.11%64.71%69.28%66.98%62.06%62.28%60.29%67.62%60.34%59.12%60.66%68.90%78.53%86.35%81.75%85.11%
Operating Expense11.36M8.65M11.27M19.82M9.11M12.63M30.31M95.50M114.49M147.64M191.01M206.54M191.32M217.04M205.09M254.81M280.53M415.99M461.63M476.91M532.14M667.36M651.17M649.87M491.96M578.65M678.11M819.33M565.77M703.24M
Operating Income24.86M25.94M29.80M22.52M-5.37M-6.07K5.01M17.13M42.09M63.78M46.94M48.41M80.73M112.99M176.52M209.16M294.65M317.69M391.11M290.99M399.17M527.56M269.83M414.22M612.73M818.12M1.16B1.33B1.18B1.19B
Operating Margin17.58%17.72%21.62%22.06%-13.41%-0.01%5.02%9.98%17.73%18.98%8.90%9.77%15.00%22.63%31.51%29.17%35.49%29.00%28.47%23.60%25.84%29.85%17.68%23.01%33.65%40.36%49.56%53.37%55.24%53.55%
EBITDA25.59M25.46M34.08M31.00M6.58M13.00M21.80M49.14M60.71M82.29M97.23M108.51M139.58M188.93M197.24M231.82M323.24M397.04M470.27M382.37M464.37M571.58M347.47M447.48M629.51M846.14M1.20B1.33B1.18B1.26B
EBITDA Margin18.09%17.39%24.72%30.35%16.44%30.93%21.85%28.62%25.57%24.48%18.43%21.89%25.93%37.83%35.20%32.33%38.93%36.25%34.23%31.01%30.06%32.34%22.77%24.86%34.57%41.74%51.33%53.52%55.17%56.74%
Net Income18.90M19.98M22.00M18.17M-2.80M1.45M5.33M3.64M4.51M6.15M10.36M12.28M13.69M34.41M70.54M93.75M121.59M153.28M217.38M152.46M198.39M243.20M129.69M204.10M290.76M380.26M526.86M585.26M515.59M535.08M
Net Income Margin13.36%13.65%15.96%17.79%-7.00%3.46%5.34%2.12%1.90%1.83%1.96%2.48%2.54%6.89%12.59%13.08%14.65%13.99%15.82%12.36%12.84%13.76%8.50%11.34%15.97%18.76%22.51%23.56%24.16%24.01%
R&D--------------6.07M5.87M21.44M31.58M49.39M51.37M58.79M40.79M42.74M127.58M121.17M82.11M65.59M95.59M101.52M91.10M
R&D as % of Total Revenue--------------1.08%0.82%2.58%2.88%3.59%4.17%3.81%2.31%2.80%7.09%6.65%4.05%2.80%3.85%4.76%4.09%
Interest Expense4.41M4.46M3.30M2.24M4.42M7.56M9.42M15.54M16.59M23.03M24.30M28.30M28.65M34.98M18.32M14.23M13.21M11.47M51.17M65.94M29.99M1.53M6.66M1.23M688.85K435.90K524.80K579.67K504.25K-
Interest Expense % of Total Revenue3.12%3.04%2.39%2.19%11.04%18.00%9.44%9.05%6.99%6.85%4.61%5.71%5.32%7.01%3.27%1.99%1.59%1.05%3.72%5.35%1.94%0.09%0.44%0.07%0.04%0.02%0.02%0.02%0.02%-

Balance Sheet

Currency: CNY1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets194.64M221.46M238.93M370.30M399.55M484.25M561.43M715.07M755.44M952.21M934.10M993.28M1.04B1.11B1.14B1.16B1.34B1.59B1.95B2.08B2.48B2.78B2.90B3.15B3.69B3.94B4.69B5.20B4.93B5.00B
Total Liabilities115.78M118.68M116.33M107.31M140.86M238.76M308.04M415.43M445.01M608.70M570.70M599.73M596.85M582.99M488.86M390.33M395.83M431.63M472.42M401.35M532.89M556.37M558.92M585.32M759.72M536.03M629.03M701.65M518.50M647.45M
Total Equity71.01M90.91M112.26M252.05M249.04M245.49M251.89M256.59M262.31M276.67M286.29M302.87M317.35M351.76M417.65M511.66M633.26M768.26M967.62M1.10B1.28B1.50B1.60B1.73B1.95B2.24B2.58B2.98B2.91B2.86B
Cash7.15M1.72M12.70M131.08M66.66M19.46M77.00M94.92M85.00M58.79M42.53M71.22M130.03M166.45M203.87M154.48M248.00M273.37M426.24M414.62M616.19M706.86M1.01B953.90M1.49B1.22B1.84B2.05B2.12B2.01B
Total Debt31.84M47.50M42.80M18.92M52.26M128.56M216.30M272.47M253.30M366.24M370.78M305.14M260.27M306.85M230.30M157.74M149.23M87.49M94.08M54.24M40.50M21.00M20.00M20.00M29.92M9.02M7.89M66.95K2.86M-
Net Debt24.69M45.78M30.10M-112.17M-14.40M109.10M139.30M177.55M168.30M307.45M328.25M233.91M130.24M140.40M26.42M3.26M-98.76M-185.88M-332.16M-360.38M-575.69M-685.86M-991.23M-933.90M-1.46B-1.21B-1.84B-2.05B-2.12B-

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow24.20M45.19M-90.48M-133.16K-16.53M2.43M30.52M63.38M51.95M101.20M93.80M129.39M189.51M139.09M163.48M216.05M272.41M290.24M500.91M426.11M538.56M243.54M735.55M755.85M1.20B1.17B929.61M1.27B
Investing Cash Flow-4.02M-36.51M1.57M-81.82M-8.04M-57.66M-35.36M-41.70M-28.68M-30.04M-26.71M-76.61M14.82M-49.11M-52.77M-65.74M-41.50M-160.65M-300.27M-100.40M-69.84M-187.29M-37.90M-768.61M-328.22M-181.30M185.53M-
Financing Cash Flow-9.20M109.70M24.49M34.75M82.11M73.15M-5.09M-48.60M-39.53M-42.47M-8.29M-16.36M-180.64M-157.86M11.81M-137.68M-80.21M-126.25M-89.30M-154.16M-158.63M-134.71M-140.94M-268.23M-331.78M-696.68M-1.09B-
Capital Expenditure926.36K7.08M3.27M86.94M16.79M34.19M15.40M52.96M29.93M26.51M34.39M72.52M38.85M57.76M56.32M66.67M80.76M80.73M229.81M177.80M131.46M172.48M101.77M120.34M89.68M50.61M43.64M48.32M
Free Cash Flow23.27M38.11M-93.76M-87.07M-33.32M-31.75M15.12M10.41M22.02M74.68M59.41M56.87M150.67M81.34M107.16M149.39M191.65M209.51M271.10M248.31M407.11M71.07M633.79M635.51M1.11B1.12B885.97M1.22B
Dividends Paid3.30M7.39M8.85M7.55M7.13M20.72M18.72M29.36M37.63M33.34M42.56M19.06M14.05M15.24M9.74M25.56M26.60M21.41M21.99M28.52M52.42M70.30M70.30M105.15M339.67M690.88M585.80M585.83M
FCF to OCF96.17%84.33%103.62%65390.40%201.61%-1305.36%49.53%16.43%42.39%73.80%63.34%43.95%79.50%58.48%65.55%69.14%70.35%72.19%54.12%58.27%75.59%29.18%86.16%84.08%92.50%95.69%95.31%96.20%
Dividend Paid to FCF14.16%19.40%-9.44%-8.67%-21.39%-65.25%123.81%281.98%170.90%44.64%71.64%33.51%9.33%18.74%9.09%17.11%13.88%10.22%8.11%11.48%12.88%98.92%11.09%16.55%30.69%61.46%66.12%47.89%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Oct 23, 2014Feb 13, 2015Apr 23, 2015Jul 24, 2015Oct 22, 2015Feb 26, 2016Apr 26, 2016Jul 27, 2016Oct 25, 2016Mar 3, 2017Apr 27, 2017Jul 27, 2017Oct 26, 2017Feb 12, 2018Apr 27, 2018Aug 8, 2018Oct 25, 2018Mar 27, 2019Apr 27, 2019Aug 9, 2019Oct 25, 2019Mar 6, 2020Apr 24, 2020Aug 7, 2020Oct 23, 2020Jan 15, 2021Apr 23, 2021Jul 29, 2021Oct 22, 2021Jan 18, 2022Apr 14, 2022Jul 29, 2022Oct 19, 2022Jan 19, 2023Apr 14, 2023Jul 7, 2023Oct 19, 2023Jan 19, 2024Apr 17, 2024Jul 9, 2024Oct 25, 2024Mar 20, 2025Apr 16, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate------------------------------------------------------------------
EPS Actual0.020.080.140.060.120.080.130.070.130.100.130.160.160.180.150.170.210.110.270.340.180.090.080.300.200.250.230.170.370.260.300.120.320.030.26-0.060.100.280.280.210.210.370.400.270.470.510.380.260.670.630.670.280.700.670.590.530.720.700.140.640.780.660.300.540.470.48
Surprise------------------------------------------------------------------
Timing------------------Pre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours-----

Key Statistics & Ratios

Market Cap5.58B
Enterprise Value3.47B
Trailing P/E13.31
Forward P/E24.81
PEG Ratio0.00
Price / Sales2.93
Price / Book2.17
EPS1.79
Book Value11.16
Revenue (TTM)1.91B
Gross Profit (TTM)1.59B
EBITDA946.33M
Profit Margin22.09%
Operating Margin44.31%
Return on Equity20.17%
Return on Assets12.52%
Shares Outstanding234.33M
Shares Float159.95M
Beta0.06
Dividend Yield10.60%
Dividend Rate2.50
Payout Ratio139.11%

Dividends

20261×
2.00Jul 1, 2026
20252×
0.50Oct 17, 20252.00Jun 11, 2025
20242×
0.50Sep 27, 20242.00May 16, 2024
20231×
0.80May 12, 2023
20221×
0.80Apr 27, 2022
20211×
0.35Jun 1, 2021
20201×
0.30Jun 24, 2020
20191×
0.30Jun 21, 2019
20181×
0.25Jul 18, 2018
20171×
0.12Jun 16, 2017
20161×
0.08Jul 8, 2016
20151×
0.08May 8, 2015
20141×
0.08Jun 26, 2014
20131×
0.08Apr 18, 2013
20021×
0.01Sep 27, 2002
19991×
0.01Sep 13, 1999

Stock Splits

  • Jun 16, 201713:10
  • Jul 20, 200613.74:10
  • Sep 27, 20021.7:1